본문 바로가기
  • Home

A Case of Improvement on Post-COVID-19 Sequelae Using Ortho-Cellular Nutrition Therapy (OCNT)

  • CELLMED
  • Abbr : CellMed
  • 2026, 16(1), pp.1~1
  • DOI : 10.5667/CellMed.spc.152
  • Publisher : Cellmed Orthocellular Medicine and Pharmaceutical Association
  • Research Area : Medicine and Pharmacy > General Medicine
  • Received : January 28, 2026
  • Accepted : January 30, 2026
  • Published : January 30, 2026

Jong-Bin Jo 1

1화순종로약국

Irregular Papers

ABSTRACT

Objective: Coronavirus Disease 2019 (COVID-19) was first recognized in December 2019 following a cluster of pneumonia of unknown etiology in Wuhan, Hubei Province, China. In response to the pandemic, multiple COVID-19 vaccines were developed and deployed globally in 2021, and a nationwide vaccination program was also implemented in South Korea. Nevertheless, the emergence of the Delta and Omicron variants was accompanied by frequent breakthrough infections, and a subset of individuals subsequently developed post-acute sequelae. Case Report: The patient in this case was a Korean woman in her 50s who, because of workplace requirements, received a third dose of a COVID-19 vaccine. Subsequently, she experienced persistent, progressively worsening fatigue and functional decline. She visited a pharmacy and initiated Ortho-Cellular Nutrition Therapy (OCNT) containing iodine, folate, iron, anthocyanins, and fructo-oligosaccharides. Following this intervention, she showed clinical improvement in symptoms consistent with post-COVID-19 sequelae, including fatigue, lethargy, and low body temperature. Conclusion: Because this is a single-patient case report of post-COVID-19 sequelae, the findings have limited generalizability to the broader patient population. Nevertheless, the patient exhibited marked clinical improvement after five months of OCNT, which was considered clinically meaningful; accordingly, this case is reported.

Journal Copyright Policy

BY-NC 아이콘

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.

Citation status

* References for papers published after 2025 are currently being built.